SMAD2 and Alzheimer disease: Furthermore, our results indicate that Id2 functions at least partially through negative regulation of the TGFβ/Smad pathway as Id2 binds both TGFβ and Smad2/3 and suppression of Id2 in AD cells activated Smad signaling and phenotypic transition to an AI-like state.